Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325) |
---|
09/30/2008 | CA2355470C Benzoheterocycles and their use as mek inhibitors |
09/25/2008 | WO2008113760A2 Arylsulphonyglycine derivatives as suppressors of the interaction of glycogen phosphorylase a with the gl subunit of glycogen-associated protein phosphatase 1 (ppl) for the treatment of metabolic disorders, particulary diabetes |
09/25/2008 | WO2007126934A3 Amidoethylthioether orexin receptor antagonists |
09/25/2008 | US20080234290 New indole or benzimidazole derivatives as cb1 inverse agonists |
09/25/2008 | US20080234278 Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions |
09/25/2008 | US20080234266 Squaric Acid Derivatives II |
09/25/2008 | CA2681124A1 New substituted arylsulphonylglycines, the preparation thereof and the use thereof as pharmaceutical compositions |
09/24/2008 | EP1885725B1 Tricyclic azole derivatives, their manufacture and use as pharmaceutical agents |
09/24/2008 | EP1509528B1 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
09/24/2008 | CN101273019A Novel benzimidazole and benzothiazole derivatives, method for preparing same, use thereof as drugs, pharmaceutical compositions and novel use especially as C-Met inhibitors |
09/24/2008 | CN101270091A Method for preparing albendazole |
09/24/2008 | CN101270090A Method for preparing albendazole oxide |
09/24/2008 | CN101270089A Chromogen containing benzimidazole and synthesizing process |
09/23/2008 | CA2450093C Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments |
09/23/2008 | CA2379747C Novel succinate derivative compounds useful as cysteine protease inhibitors |
09/23/2008 | CA2378382C Carboxylic acid amides, pharmaceutical compositions containing these compounds, the use and preparation thereof |
09/23/2008 | CA2337825C Disubstituted bicyclic heterocycles, the preparation thereof and their use as pharmaceutical compositions |
09/17/2008 | EP1968949A1 Improved process for the preparation of the salts of 4-(benzimidazolylmethylamino)-benzamides |
09/17/2008 | EP1968948A2 Novel hydrogen sulfate salt |
09/17/2008 | EP1392639B1 Pyruvate derivatives |
09/17/2008 | CN101268043A Amino-alkyl-amide derivatives as CCR3 receptor ligands |
09/17/2008 | CN101266847A 2-mercaptobenzimidazole application for anti-oxidation on the surface of the cable conductor |
09/17/2008 | CN100418953C Process for manufacture of telmisartan |
09/17/2008 | CN100418951C Cycloamine derivative and its use as medicine |
09/16/2008 | US7425642 Anti-diabetic activity, improves insulin resistance and control the blood glucose level more safely, simulates activity of peroxisome proliferator-activated receptor; (1-{(2E)-3-[3-(Bromomethyl)phenyl]prop-2-en-1-yl}-1H-pyrrol-2-yl)(4-methyl-phenyl)methanone |
09/16/2008 | US7425637 mitogen-activated protein/extracellular signal-regulated (MAP/ERK)Kinase pathways; 6-(4-bromo-2-fluorophenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxyethoxy)-amide; hyperproliferative diseases; anticarcinogenic and antiinflammatory agent |
09/16/2008 | CA2427221C Process and intermediates for preparing anti-cancer compounds |
09/16/2008 | CA2379557C Arylsulphonamide-substituted benzimidazole derivatives, processes for preparing them and their use as pharmaceutical compositions |
09/12/2008 | WO2008107322A1 Indole, benzimidazole or benzotriazole derivatives including a piperidine or piperazine core as anti-neoplasic agents or cell proliferation inhibitors |
09/11/2008 | US20080221188 (S)(-)-2-(7-chloro-6-fluoro-1H-benzimidazol-1-yl)-N-{1-[4-(1-cyano-1-methylethyl)phenyl]ethyl}acetamide; treatment of pain; vanilloid receptor inhibitor; Antagonists maintain analgesic properties, but avoid pungency and neurotoxicity side effects of agonists |
09/11/2008 | US20080221185 Psychoses, dementia or attention deficit disorder; 2-[3-(4-chlorophenyl)-2-oxo-1,4-diazaspiro[4.5]dec-3-en-1-yl]-N-[2-(methyloxy)phenyl]acetamide |
09/11/2008 | US20080221178 Benzimidazole Derivatives,Compositions Containing Them, Preparation Thereof and Uses Thereof |
09/11/2008 | US20080221082 of the alpha V beta 3 integrin receptor; , thromboembolic events, cardiovascular disorders, lung diseases, disorders of the CNS, the kidney, the gastrointestinal tract or inflammation |
09/11/2008 | US20080220286 Electroluminescent compound; high color purity, high fluorescence yield, and high electric luminance yield; easy to synthesize and can easily form films |
09/11/2008 | US20080220003 C5a Receptor Antagonists |
09/11/2008 | US20080217580 Organic Luminescent Element |
09/11/2008 | US20080216606 Grinding to uniform particle size; heating; pressurization;; extraction from ores, concentrates |
09/10/2008 | EP1966188A1 Enantioselective preparation of benzimidazole derivatives and their salts |
09/10/2008 | EP1966157A2 Substituted 1h-benzimidazole-4-carboxamides are potent parp inhibitors |
09/10/2008 | EP1966156A2 New compounds iii |
09/10/2008 | EP1966155A1 Tosylate salt of 6- (4-br0m0-2-chl0r0phenylamin0) -7-fluoro-n- (2-hydroxyethoxy) -3-methyl-3h-benzimi dazole- 5 - carboxamide , mek inhibitor useful in the treatment of cancer |
09/10/2008 | EP1965805A1 Urea derivatives useful as calcium receptor modulators |
09/10/2008 | EP1631553A4 Capture and release based isotope tagged peptides and methods for using the same |
09/10/2008 | CN101263136A Benzimidazole derivatives as 5-HT6, 5-HT24 |
09/10/2008 | CN101260081A Preparation method for N-arylazoles compounds |
09/09/2008 | US7423156 Optionally fused oxazolyl- or thiazolyl-aminophenylbenzoyl(cyclo)alkanoic acid derivatives, e.g., trans-(1R,2R)-2-({3'-fluoro-4'-,[(6-fluoro-1,3-benzothiazol-2-yl)amino]-1,1'-biphenyl-4-yl}carbonyl)cyclopentanecarboxylic acid; diacylglycerol O-acyltransferase type 1 inhibitors |
09/04/2008 | WO2008104580A1 New use of glutaminyl cyclase inhibitors |
09/04/2008 | WO2008104077A1 Small molecule inhibitors of protein arginine methyltransferases (prmts) |
09/04/2008 | US20080214801 Condensation of a specifically engineered phosphine containing a cleavable linker so that a substituent of the phosphine is transferred to the azide, releasing an oxidized phosphine by-product and producing an amide bond in final product |
09/04/2008 | US20080214613 Substituted benzimidazole compounds with dual NOS inhibitory activity and mu opioid agonist activity |
09/04/2008 | CA2679446A1 New use of glutaminyl cyclase inhibitors |
09/03/2008 | EP1962864A1 Antibacterial agents |
09/03/2008 | CN100415744C 2-arylamino-pyrimidines for the treatment of GSK3-related disorders |
09/03/2008 | CN100415723C Benzimidazole derivative |
09/03/2008 | CN100415722C 2-acetyl benzimidazolyl-glycin schiff base preparation method |
09/03/2008 | CN100415721C Method for preparing nitrobenzimidazole of containing fluorin |
09/02/2008 | US7420089 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition |
09/02/2008 | US7420001 N-({4'-[(1-benzofuran-2-ylcarbonyl)amino]-1,1'-biphenyl-4-yl}sulfonyl)glycine; metalloproteinase inhibitors; arthritis, macular degeneration, graft versus host disease, cancer, osteoarthritis |
09/02/2008 | US7419995 N-substituted benzimidazoyl c-Kit inhibitors and combinatorial benzimidazole library |
09/02/2008 | US7419967 e.g. hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-3-(cyclopentyloxy)[(3-[2-(dimethylamino)ethyl]aminophenyl)sulfonyl]amino-2-hydroxypropyl)carbamate; against human immunodeficiency virus, chronic and acute viral infections |
09/02/2008 | US7419511 Storage stability; wash-fastness and shampoo-fastness; useful for fluorescent compounds in context of lightening without need to use an oxidizing agent; internal salt of bisnaphtho[2', 3':4, 5]thiazolo[3, 2-d:2', 3'-g][1, 4]diazepin-15-ium, 16, 17-dihydro-16, 17-bis[2-(2-sulfophenyl)ethyl] |
08/28/2008 | WO2008102740A1 Organic electroluminescent device |
08/28/2008 | WO2008101586A1 Benzimidazole derivatives |
08/28/2008 | WO2007072142A3 Benzimidazole-5-carboxamide derivatives |
08/28/2008 | US20080207686 Antibiotics |
08/28/2008 | US20080207613 Selective Kinase Inhibitors |
08/28/2008 | US20080207612 Analgesics; pain management |
08/28/2008 | DE102007008420A1 Benzimidazolderivate Benzimidazole derivatives |
08/28/2008 | CA2678687A1 Benzimidazole derivatives |
08/27/2008 | EP1961745A1 Bicyclic heterocyclic compound |
08/27/2008 | EP1960382A1 Heterocyclic compounds as tyrosine kinase modulators |
08/27/2008 | CN101253185A Transition metal complex compound and organic electroluminescent device using same |
08/27/2008 | CN101250405A Novel mercapto fluorescence probe and uses thereof |
08/27/2008 | CN100413859C Sulfonated amino acid derivatives and metalloproteinase inhibitors containing same |
08/27/2008 | CN100413849C Benzimidazole derivatives |
08/26/2008 | US7417169 Amino alcohol derivatives, medicinal composition containing the same, and use of these |
08/21/2008 | WO2008101197A1 Catalysts containing n-heterocyclic carbenes for enantioselective synthesis |
08/21/2008 | WO2008098851A1 Electroluminescent metal complex |
08/21/2008 | US20080200529 Novel 2-Amino Benzimidazole Derivatives and Their Use As Modulators Of Small-Conductance Calcium-Activated Potassium Channels |
08/21/2008 | US20080200479 Acid moiety selected from pyroglutamic acid, N-(2-carboxyphenyl)-glycine acid, diglycolic acid, orotic acid, galactaric acid, nicotinic acid, hippuric acid; treatment of nervous system disorders such as schizophrenia, obsessive compulsive disorder, bipolar depression, anxiety, mania, Tourette syndrome |
08/20/2008 | EP1670790B1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
08/20/2008 | EP1670770B1 Benzimidazole derivatives, compositions containing them, preparation therof and uses thereof |
08/20/2008 | EP1660492B1 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
08/20/2008 | EP1569647B1 Cyclohexyl compounds as ccr5 antagonists |
08/20/2008 | CN101247806A SnAr process for preparing benzimidazole compounds |
08/20/2008 | CN101245049A Method for producing 5-n-butyl-2-benzoglioxaline methyl carbamate |
08/19/2008 | US7414138 e.g. 2-cyano-3-{4-[5-tert.-butyl-benzoxazol-2-yl]-phenyl}-acrylic acid 2-ethylhexyl ester; protecting human skin or human hair, and plastic material or a medicinal product that is sensitive to UV radiation from UV-A irradiation; antiaging |
08/19/2008 | US7414046 Gyrase inhibitors and uses thereof |
08/19/2008 | CA2367364C Process for nitrating aniline derivatives |
08/14/2008 | WO2008096820A1 Biphenyl derivative |
08/14/2008 | WO2008096739A1 Benzimidazole compound-containing composition and light-emitting device using the composition |
08/14/2008 | WO2008095820A1 (indol-4-yl)- or (indol-5-yl)-piperazinylmethanone derivatives for the treatment of obesity |
08/14/2008 | US20080194697 ethyl endcapped hepta- and nona-tetramethylenediamines and 1,2-bis(4-(ethylamino)butylaminomethyl)cyclopropane, used for treating prostate cancer, prostatitis and benign prostatic hyperplasia |
08/14/2008 | US20080194555 Tyrosine kinase inhibitors; antiproliferation agents; metabolism diseases; antiallergens; central nervous system disorders; vision and skin disorders; antiarthritic agents |
08/14/2008 | CA2676678A1 (indol-4-yl)- or (indol-5-yl)-piperazinylmethanone derivatives for the treatment of obesity |
08/13/2008 | EP1956013A1 Diagnostic and remedy for disease caused by amyloid aggregation and/or deposition |
08/13/2008 | EP1956008A1 Organic compound, charge-transporting material, composition for charge-transporting material and organic electroluminescent device |
08/13/2008 | EP1956007A1 Nitrogenous heterocyclic derivative and organic electroluminescence device making use of the same |
08/13/2008 | EP1955697A1 2-aminobenzamide derivative |
08/13/2008 | EP1954683A1 2-(phenyl or heterocyclic)-1h-phenantrho(9,10-d)imidazoles as mpges-1 inhibitors |